WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013154347) LIQUID FORMULATION FOR ORAL ADMINISTRATION COMPRISING AMBROXOL, LEVODROPROPIZINE AND BUFFERING AGENT, AND METHOD FOR PREPARING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/154347    International Application No.:    PCT/KR2013/002999
Publication Date: 17.10.2013 International Filing Date: 10.04.2013
IPC:
A61K 9/08 (2006.01), A61K 31/136 (2006.01), A61K 31/135 (2006.01)
Applicants: HANMI PHARM. CO., LTD. [KR/KR]; 214, Muha-ro, Paltan-myeon, Hwaseong-si, Gyeonggi-do 445-910 (KR)
Inventors: KIM, Yong Il; (KR).
KIM, Jin Cheul; (KR).
KIM, Jae Ho; (KR).
KIM, Yo Han; (KR).
PARK, Jae Hyun; (KR).
WOO, Jong Soo; (KR)
Agent: FIRSTLAW P.C.; 60 Mabang-Ro, Seocho-Ku, Seoul 137-739 (KR)
Priority Data:
10-2012-0037409 10.04.2012 KR
Title (EN) LIQUID FORMULATION FOR ORAL ADMINISTRATION COMPRISING AMBROXOL, LEVODROPROPIZINE AND BUFFERING AGENT, AND METHOD FOR PREPARING THE SAME
(FR) FORMULATION LIQUIDE DESTINÉE À UNE ADMINISTRATION ORALE COMPRENANT DE L'AMBROXOL, DE LA LÉVODROPROPIZINE ET UN AGENT TAMPON, ET SON PROCÉDÉ DE PRÉPARATION
Abstract: front page image
(EN)A liquid formulation for oral administration comprising ambroxol, levodropropizine and a buffering agent, and a method for preparing such formulation are provided. This liquid formulation shows enhanced storage stability over time and improved patient compliance, and thus can be safely used for the treatment of acute and chronic cough.
(FR)L'invention concerne une formulation liquide destinée à une administration orale comprenant de l'ambroxol, de la lévodropropizine et un agent tampon, et un procédé de préparation d'une telle formulation. La présente formulation liquide montre une stabilité à l'entreposage augmentée au cours du temps et une observance améliorée du patient et, ainsi, peut être utilisée de manière sûre pour le traitement de la toux aiguë et chronique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)